Prodotti competitors / Area Oncology 23 febbraio 2024 pembrolizumab (Keytruda): positive CHMP opinion to extension indication to include the pre- and post-operative treatment of adults whose non-small cell lung carcinoma can be removed by surgery and who are at high risk of recurrence.
Regulatory news / Area Liver Normativa europea / Area Liver 26 gennaio 2024 EMA opens a public consultation on its Concept paper for the HBV guideline revision
Prodotti competitors Regulatory news 23 gennaio 2024 FDA granted full approval for erdafitinib in 2L mUC
Associazioni 12 gennaio 2024 Think Thank ITHACA: una proposta per un nuovo meccanismo di Early Access in Italia
Autorità nazionali / Area COVID-19 Prodotti GS / Area COVID-19 8 gennaio 2024 Modifica Registri Veklury (remdesivir)
Prodotti competitors / Area Kite 4 dicembre 2023 FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma
Prodotti competitors / Area Liver 14 novembre 2023 Viral Hepatitis HBV/HBV Cure [AASLD 2023] Roche releases positive interim off-treatment results from their Ph2 PIRANGA trial testing xalnesiran (siRNA) combinations in chronic hepatitis B (CHB)
Prodotti competitors / Area Onco-Ema, Area Kite 7 novembre 2023 Abecma (idecabtagene vicleucel) ricomincia iter di P&R in AIFA con classificazione finale in H
